BTIG Maintains Buy on Oncology Institute, Raises Price Target to $8

Benzinga Newsdesk www.benzinga.com Positive 80.3%

Neg 0% Neu 0% Pos 80.3%

BTIG analyst David Larsen maintains Oncology Institute (NASDAQ:TOI) with a Buy and raises the price target from $7 to $8.